watch volumes coming down into the 31st Oct. Weakness after that date would be a problem however volume buying should see it run for a while.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025